Grant: CIHR Fellowship
University of Toronto
$45,000.00
Cellular destruction at the atomic level: understanding the dynamic activation and regulation of caspase proteases
FY 2020-21
Summary
Human cells use a process known as 'apoptosis' or programmed cell death to selectively destroy damaged cells and prevent overgrowth. In many types of cancer, cancerous cells have shut off apoptosis, which leads to rapid tumor growth and resistance to chemotherapy. In Alzheimer's disease, aberrant apoptosis contributes to the death of neuronal cells and causes progressive degeneration. At the molecular level, apoptosis signaling leads to formation of the apoptosome, a large signaling complex that activates a class of proteases known as caspases, which cleave thousands of cellular proteins, including the Alzheimer's-related proteins Tau and amyloid precursor protein. Understanding the structural basis for how caspases become activated by the apoptosome and how caspases interact with native substrates will provide novel, fundamental insight into the early stages of both cancer and Alzheimer's disease. My research will offer atomic-resolution details about apoptotic signaling and the activation of caspase proteases, and the results from this work could identify targets for new drugs that may be able to selectively destroy cancerous cells or inhibit cell death in Alzheimer's.
Department
Program
CIHR Fellowship
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
441113
Name
Alderson Thomas R
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Cellular destruction at the atomic level: understanding the dynamic activation and regulation of caspase proteases
Programtype2
Fellowship Programs
Orgnameinp2
University of Toronto
Cihramount2
$45,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Alzheimer'S; Apoptosis; Apoptosome; Cancer; Caspase; Dementia; Nuclear Magnetic Resonance (Nmr); Structural Biology; Tau
Abstract
Human cells use a process known as 'apoptosis' or programmed cell death to selectively destroy damaged cells and prevent overgrowth. In many types of cancer, cancerous cells have shut off apoptosis, which leads to rapid tumor growth and resistance to chemotherapy. In Alzheimer's disease, aberrant apoptosis contributes to the death of neuronal cells and causes progressive degeneration. At the molecular level, apoptosis signaling leads to formation of the apoptosome, a large signaling complex that activates a class of proteases known as caspases, which cleave thousands of cellular proteins, including the Alzheimer's-related proteins Tau and amyloid precursor protein. Understanding the structural basis for how caspases become activated by the apoptosome and how caspases interact with native substrates will provide novel, fundamental insight into the early stages of both cancer and Alzheimer's disease. My research will offer atomic-resolution details about apoptotic signaling and the activation of caspase proteases, and the results from this work could identify targets for new drugs that may be able to selectively destroy cancerous cells or inhibit cell death in Alzheimer's.
Competitiondate
202012
Approvedterm2
1 yr 0 mth
Pinamesdelim
Alderson, Thomas R
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $45,000~ $0~